Successfully negotiated the resolution of a False Claims Act case involving a group of imaging centers accused of Stark Law and Anti-Kickback Statute violations and improper billing practices, which resulted in a favorable settlement and declination of any administrative action by the Office of Inspector General for the Department of Health and Human Services.
Resolution of FCA Case Involving Imaging Centers
You Also May Be Interested In:
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
Served as lead counsel to BriovaRx Infusion Services in obtaining a Certificate of Need to expand services in Middle Tennessee